Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001799191-22-000058

Chief Operating Officer bought 73,684 shares at $0.95 ($70,000)

From the SEC's structured data for this filing

Trades in this filing

Miller Matthew P · Chief Operating Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-12-16 Purchase : show line 1 in the form +73,684 $0.95 $70,000 175,325 D
Open-market purchases · 73,684 sh · avg $0.95 · $70,000
Loading xslF345X03/edgardoc.xml…